Olvi Returns Its Financial Outlook Olvi plc Inside information 8 August 2023 at 5.50 p.m. Olvi Returns Its Financial Outlook Olvi Groups adjusted operating result for the…
Genelux Corporation Announces Publication of Phase I Trial Results of Intrapleural Administration of Olvi-Vec in Patients with Malignant Pleural Effusion from Mesothelioma, Lung or Breast Cancers in Frontiers in Immunology WESTLAKE VILLAGE, Calif., July 10, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company,…
Genelux Corporation Announces Publication of Positive Topline Data from Phase 2 VIRO-15 Trial Evaluating Olvimulogene Nanivacirepvec (Olvi-Vec) in Platinum-Resistant or Refractory Ovarian Cancer in the Journal of the American Medical Association (JAM WESTLAKE VILLAGE, Calif., May 25, 2023 (GLOBE NEWSWIRE) -- Genelux Corporation (NASDAQ: GNLX), a late clinical-stage immuno-oncology company, today…
Belarusian Local Court Ruled on a Fine of 11,6 Million Euro for Lidskoe Pivo Olvi plc Inside information 29 March 2023 at 6.00 pm. Belarusian Local Court Ruled on a Fine of 11,6 Million Euro…
Correction to the release: Olvi Plc to Initiate Repurchase of Shares Olvi Plc Stock Exchange Release - Changes in companys own shares 2 March 2023 at 11.00 am Correction to the release: Olvi…
Olvi Plc to Initiate Repurchase of Shares Olvi Plc Stock Exchange Release - Changes in companys own shares 2 March 2023 at 10.15 am Olvi Plc to Initiate Repurchase…
Notice of Annual General Meeting Olvi plc Notice of Annual General Meeting 28 February 2023 at 3.00 pm Notice of Annual General Meeting The shareholders of Olvi…